ARV Facts

Facts about Antiretroviral Drugs

Arrow to the left Back to the Homepage

Active substance: Efivarenz
Manufacturer: Bristol-Myers Squibb (UK)

Extract from the prescribing information:

"Patients should be informed that SUSTIVA is not a cure for HIV-1 infection and that they may continue to develop opportunistic infections and other complications associated with HIV-1 disease. Patients should be told that there are currently no data demonstrating that SUSTIVA therapy can reduce the risk of transmitting HIV to others through sexual contact or blood contamination."

The above has been extracted from the Sustiva prescribing information on the Bristol-Myers Squibb webpages.